Biotech Stocks

Is the Worst Over for Zogenix (ZGNX) Stock?

Zogenix (ZGNX) is one of the pharma’s biggest losers today. The reason?

Analyst Sings the Praises of Amarin (AMRN) Stock Following ADA Endorsement

With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes …

Stifel on Amarin (AMRN): Nothing Fishy About This Stock — It’s a Buy!

Do you have high cholesterol? Investors in Amarin (AMRN) kind of hope that you do — but ideally, not too high.

This Analyst Takes Biogen (BIIB) Alzheimer’s Failure Personally

It’s a short and dramatic plunge for Biogen (BIIB) stock. Today, the biotech giant’s shares lost 29% of their value and reached levels …

Spark Therapeutics (ONCE): Did You Feel the Ground Shake, Too?

It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …

Keep Faith in Bausch Health (BHA) Stock, Say Analysts

Bausch Health (BHC) saw its shares crater by as much as 10% today on exceptionally high volume. This drop was triggered by the release …

Teva Stock Slips on Back of Weak 2019 Outlook; Analysts Weigh In

You know there was some bad news with a company’s quarterly update when the stock tanks after the results are announced. That’s what …

Don’t Say Bye Bye to Intercept (ICPT) Stock, Say Buy Buy

With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …

MacroGenics (MGNX) Stock Fires on All Cylinders; Analysts Weigh In

It’s a very rewarding trading day for investors in MacroGenics (MGNX) with shares up over 120%, making the stock Wall Street’s bull of …

Trevena (TRVN) Stock Roars Back to Life; Analysts Dive In

Shares of Trevena (TRVN) came back to life. The struggling biotech stock took a rare leap upward last week, as well as today, as resolution …